Thank you, Mr. Chair. That's much appreciated.
Before I ask witnesses questions, I would like to make a comment. I know that this is not common practice in the committee, but I would still like to send a message to the Conservative members opposite. Earlier, Ms. Adams talked about what the Conservative government had announced in the Speech from the Throne regarding the drug policy's renewal. Since we began our study, the government has not seemed to be open to what I have suggested to all the experts regarding harm reduction, which was the fourth pillar of the National Anti-Drug Strategy before the policy change, in 2007. My colleague Libby Davies suggested the same thing to Dr. Selby and Mr. MacPherson.
Since we began studying this issue, I have clearly seen that health experts want the Government of Canada to reintroduce harm reduction into the drug policy. I really hope that the Conservative government will heed the experts' advice.
Dr. Selby and Mr. MacPherson, thank you for once again reminding us how important it is to include harm reduction in our drug policy.
My next question is for Mr. MacPherson.
You spoke to us in your presentation about the guidelines regarding opiate prescriptions. Could you elaborate on that? What kind of guidelines did you have in mind when you talk about opiate prescription guidelines?